Frank Litvack is of CAPRICOR THERAPEUTICS, INC.. Currently has a direct ownership of 133,269 shares of CAPR, which is worth approximately $2.93 Million. The most recent transaction as insider was on Aug 14, 2023, when has been sold 4,364 shares (Common Stock) at a price of $6.61 per share, resulting in proceeds of $28,846. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 133K
0% 3M change
0% 12M change
Total Value Held $2.93 Million

Frank Litvack Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 14 2023
SELL
Payment of exercise price or tax liability
$28,846 $6.61 p/Share
4,364 Reduced 3.17%
133,269 Common Stock
Aug 14 2023
BUY
Exercise of conversion of derivative security
$28,839 $1.39 p/Share
20,748 Added 13.1%
137,633 Common Stock
Feb 21 2023
SELL
Payment of exercise price or tax liability
$19,498 $4.31 p/Share
4,524 Reduced 3.19%
137,276 Common Stock
Feb 21 2023
BUY
Exercise of conversion of derivative security
$19,497 $1.39 p/Share
14,027 Added 9.0%
141,800 Common Stock
Jan 03 2022
SELL
Payment of exercise price or tax liability
$214,815 $3.18 p/Share
67,552 Reduced 38.62%
107,382 Common Stock
Jan 03 2022
BUY
Exercise of conversion of derivative security
$214,815 $1.39 p/Share
154,543 Added 46.91%
174,934 Common Stock
FL

Frank Litvack

Beverly Hills, CA

Track Institutional and Insider Activities on CAPR

Follow CAPRICOR THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CAPR shares.

Notify only if

Insider Trading

Get notified when an Capricor Therapeutics, Inc. insider buys or sells CAPR shares.

Notify only if

News

Receive news related to CAPRICOR THERAPEUTICS, INC.

Track Activities on CAPR